The ethics of non-inferiority trials.

摘要

Silvio Garattini and Vittorio Bertele'1 state that non-inferiority designs are unethical and should be banned because they offer no advantage to present and future patients. Although we appreciate their concerns, we believe the conclusion is fundamentally incorrect and a possible barrier to future clinical research in neglected diseases.